AGNISTABIO

Pharmaceutical preparations for the treatment of inflammatory diseases, immune related diseases, disorders and conditions; biological preparations for the treatment of inflammatory diseases, immune related diseases, disorders and conditions; pharmaceutical preparations for the treatment of cancer, tumor, malignancies, and related diseases, disorders, and conditions; biological preparations for the treatment of cancer, tumor, malignancies, and related diseases, disorders, and conditions; pharmaceutical preparations for the treatment of eye diseases; biological preparations for the treatment of eye diseases; pharmaceutical preparations for the treatment of cardiovascular diseases; biological preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of brain disorders; biological preparations for the treatment of brain disorders

Medical and scientific research in the field of inflammatory diseases, immune related diseases, disorders, and conditions treatment and diagnosis; medical and scientific research in the field of cancer, tumors, malignancies, and related diseases, disorders and conditions treatment and diagnosis; Medical and scientific research in the field of eye diseases, cardiovascular diseases and brain disorders treatment and diagnosis; Clinical research in the field of inflammatory diseases, immune related diseases, disorders, and conditions; Clinical research in the field of cancer, tumors, malignancies, and related diseases, disorders and conditions; Clinical research in the field of eye diseases, cardiovascular diseases and brain disorders, and conditions; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical research and development; Scientific research and development; Conducting early evaluations in the field of new pharmaceuticals; Research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical and biopharmaceutical research services in the fields of inflammatory diseases, immune related diseases, disorders, and conditions; cancer, tumors, malignancies, and related diseases, disorders, conditions; eye diseases; cardiovascular diseases; and brain disorders; Pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; Pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services; Software as a service services for artificial intelligence software for drug discovery and development; Scientific and technological services and research and design relating thereto; Industrial analysis and research services; Design and development of computer hardware and software; Legal services - Scientific and technological services and research and design relating thereto; Industrial analysis and research services; Design and development of computer hardware and software; legal services

Providing information in the field of inflammatory disease, immune related diseases, disorders and conditions prevention, screening, diagnosis and treatment; providing information in the field of cancer, tumor, malignancies, and related diseases, disorders, and conditions prevention, screening, diagnosis and treatment; providing information in the field of eye diseases, cardiovascular diseases, and brain disorder prevention, screening, diagnosis and treatment

Licensing of intellectual property; Licensing of intellectual property in the field of pharmaceuticals; Licensing of intellectual property in the field of medical and scientific technologies